FlyteHealth Achieves General Availability in the CMS Health Technology Ecosystem, Recognized at One-Year Anniversary Event in Washington, D.C.
FlyteHealth and State of Connecticut Evaluation Demonstrates Significant Medical Cost Savings and Nearly $30 Million in Pharmacy Cost Avoidance
FlyteHealth to Expand Direct Access to Obesity Management Medication for Employers
FlyteHealth Featured for U.S. Medicare ACCESS Program, Marking a Major Step Forward in Scalable Cardio-Kidney Metabolic Care
Beyond GLP-1s: Withings Health Solutions Unveils Best Practices for Obesity Care Management Programs
FlyteHealth and Heartbeat Health Collaborate to Deliver Integrated Cardiometabolic and Cardiovascular Care
FlyteHealth Announces Executive Leadership Expansion Amidst Continued Growth
White paper urges FDA to act against companies producing counterfeit GLP-1s
New Standards of Care offer ‘tailor-made recommendations’ for treating obesity
How FlyteHealth Is Changing the Way We Treat Obesity
FlyteHealth Obesity Care Program Demonstrates Cost Avoidance and Noteworthy Medication Adherence in Year-One Outcomes
Patients navigate an ‘absolutely insane’ maze to afford weight-loss drugs
Tirzepatide bests semaglutide for weight loss in adults with obesity
Zepbound Patients Fear Losing Coverage After CVS Deal for Wegovy
New weight loss pill could benefit people with Type 2 diabetes: Eli Lilly
FlyteHealth Executive Board Chair, Dr. Cheryl Pegus, Co-Chair of newly launched Duke-Margolis Health Capital Impact Council
Amy Schumer on switching weight-loss medications
Microdosing weight-loss drugs goes viral, and worries experts
Read at Bloomberg (subscription required)
NovoCare Pharmacy may improve access to Wegovy, but concerns about affordability remain
End of the line for BMI? Experts propose new obesity definition
Reat at Newsweek
